| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 136, 5469-5475, Copyright © 1995 by Endocrine Society
ARTICLES |
N Franchimont and E Canalis
Department of Research, Saint Francis Hospital and Medical Center, Hartford, Connecticut 06105, USA.
Platelet-derived growth factor (PDGF) increases bone resorption and the number of osteoclasts in calvarial sections, and it may regulate local cytokines involved in bone remodeling. Interleukin-6 (IL-6), a cytokine secreted by osteoblasts, osteoclasts, and stromal cells, is known to increase osteoclast recruitment. We tested the effects of PDGF on IL-6 expression in cultures of osteoblast-enriched cells from 22-day-old fetal rat calvariae (Ob cells). Treatment of Ob cells with PDGF BB caused a time- and dose-dependent induction of IL-6 messenger RNA (mRNA), as determined by Northern blot analysis. The effect was maximal after 1 h of treatment and was observed with PDGF BB at 0.3-3.3 nM. Treatment with PDGF BB for 24 h also increased IL-6 polypeptide levels in the culture medium, as determined by a specific bioassay. Although PDGF AA increased IL-6 mRNA levels, its effect was less pronounced than that of PDGF BB. Phorbol 12-myristate 13-acetate (PMA) induced IL-6 transcripts, and the effect of PDGF BB was inhibited in the presence of the protein kinase C (PKC) inhibitor, sangivamycin, or after down- regulation of PKC by PMA preincubation. Although forskolin increased IL- 6 mRNA levels, PDGF BB did not induce cAMP production in Ob cells. The calcium ionophore, ionomycin, enhanced IL-6 transcripts in Ob cells and the intracellular calcium chelator, 1,2-bis-(o-aminophenoxy)ethane- N,N,N',N'-tetraacetic acid tetra-(acetoxymethyl)-ester, inhibited the induction of IL-6 transcripts by PDGF BB, PMA, and PTH. In conclusion, PDGF BB stimulates IL-6 expression in Ob cells, a response that is PKC and calcium dependent. The increase in IL-6 expression may be relevant to the actions of PDGF BB on bone resorption.
This article has been cited by other articles:
![]() |
D. C. Lev, S. J. Kim, A. Onn, V. Stone, D.-H. Nam, S. Yazici, I. J. Fidler, and J. E. Price Inhibition of Platelet-Derived Growth Factor Receptor Signaling Restricts the Growth of Human Breast Cancer in the Bone of Nude Mice Clin. Cancer Res., January 1, 2005; 11(1): 306 - 314. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guillen, P. Martinez, A. R. de Gortazar, M. E. Martinez, and P. Esbrit Both N- and C-terminal Domains of Parathyroid Hormone-related Protein Increase Interleukin-6 by Nuclear Factor-kappa B Activation in Osteoblastic Cells J. Biol. Chem., July 26, 2002; 277(31): 28109 - 28117. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. ValIn, C. Guillen, and P. Esbrit C-Terminal Parathyroid Hormone-Related Protein (PTHrP) (107-139) Stimulates Intracellular Ca2+ through a Receptor Different from the Type 1 PTH/PTHrP Receptor in Osteoblastic Osteosarcoma UMR 106 Cells Endocrinology, July 1, 2001; 142(7): 2752 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Manolagas Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis Endocr. Rev., April 1, 2000; 21(2): 115 - 137. [Abstract] [Full Text] |
||||
![]() |
M. Miwa, O. Kozawa, H. Tokuda, and T. Uematsu Mitogen-Activated Protein (MAP) Kinases Are Involved in Interleukin-1 (IL-1)-Induced IL-6 Synthesis in Osteoblasts: Modulation Not of p38 MAP Kinase, But of p42/p44 MAP Kinase by IL-1-Activated Protein Kinase C Endocrinology, November 1, 1999; 140(11): 5120 - 5125. [Abstract] [Full Text] |
||||
![]() |
N. Franchimont, D. Durant, S. Rydziel, and E. Canalis Platelet-derived Growth Factor Induces Interleukin-6 Transcription in Osteoblasts through the Activator Protein-1 Complex and Activating Transcription Factor-2 J. Biol. Chem., March 5, 1999; 274(10): 6783 - 6789. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tokuda, O. Kozawa, A. Harada, K.-i. Isobe, and T. Uematsu Triiodothyronine Modulates Interleukin-6 Synthesis in Osteoblasts: Inhibitions in Protein Kinase A and C Pathways Endocrinology, March 1, 1998; 139(3): 1300 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Kozawa, A. Suzuki, T. Kaida, H. Tokuda, and T. Uematsu Tumor Necrosis Factor-alpha Autoregulates Interleukin-6 Synthesis via Activation of Protein Kinase C. FUNCTION OF SPHINGOSINE 1-PHOSPHATE AND PHOSPHATIDYLCHOLINE-SPECIFIC PHOSPHOLIPASE C J. Biol. Chem., October 3, 1997; 272(40): 25099 - 25104. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wakikawa, A. Shioi, M. Hino, M. Inaba, Y. Nishizawa, N. Tatsumi, H. Morii, and S. Otani Thrombopoietin Inhibits in Vitro Osteoclastogenesis from Murine Bone Marrow Cells Endocrinology, October 1, 1997; 138(10): 4160 - 4166. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Franchimont, D. Durant, and E. Canalis Interleukin-6 and Its Soluble Receptor Regulate the Expression of Insulin-Like Growth Factor Binding Protein-5 in Osteoblast Cultures Endocrinology, August 1, 1997; 138(8): 3380 - 3386. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Franchimont, S. Rydziel, A. M. Delany, and E. Canalis Interleukin-6 and Its Soluble Receptor Cause a Marked Induction of Collagenase 3 Expression in Rat Osteoblast Cultures J. Biol. Chem., May 2, 1997; 272(18): 12144 - 12150. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Biasucci, A. Vitelli, G. Liuzzo, S. Altamura, G. Caligiuri, C. Monaco, A. G. Rebuzzi, G. Ciliberto, and A. Maseri Elevated Levels of Interleukin-6 in Unstable Angina Circulation, September 1, 1996; 94(5): 874 - 877. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |